Does TRAMETINIB Cause Malignant neoplasm progression? 807 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 807 reports of Malignant neoplasm progression have been filed in association with TRAMETINIB. This represents 13.8% of all adverse event reports for TRAMETINIB.
807
Reports of Malignant neoplasm progression with TRAMETINIB
13.8%
of all TRAMETINIB reports
320
Deaths
205
Hospitalizations
How Dangerous Is Malignant neoplasm progression From TRAMETINIB?
Of the 807 reports, 320 (39.7%) resulted in death, 205 (25.4%) required hospitalization, and 48 (5.9%) were considered life-threatening.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRAMETINIB. However, 807 reports have been filed with the FAERS database.
What Other Side Effects Does TRAMETINIB Cause?
Pyrexia (1,096)
Product use in unapproved indication (349)
Diarrhoea (325)
Nausea (301)
Rash (290)
Vomiting (289)
Fatigue (269)
Death (240)
Chills (227)
Asthenia (193)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which TRAMETINIB Alternatives Have Lower Malignant neoplasm progression Risk?
TRAMETINIB vs TRAMETINIB DIMETHYL SULFOXIDE
TRAMETINIB vs TRANDOLAPRIL
TRAMETINIB vs TRANDOLAPRIL\VERAPAMIL
TRAMETINIB vs TRANEXAMIC ACID
TRAMETINIB vs TRANYLCYPROMINE